Zacks.com on MSN
Can Amgen's MariTide Take on Leaders in the Obesity Space?
AMGN's MariTide enters late-stage obesity trials with monthly dosing but faces rising competition as Eli Lilly and Novo ...
21hon MSN
Novo Nordisk's long game on weight loss drugs sparks hope in science, but the Street is impatient
Novo Nordisk has had a difficult year: a tumbling stock price resulting in the biggest leadership shakeup in the company's ...
The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...
Medically reviewed by Sanja Jelic, MD Obstructive sleep apnea (OSA) is the most common form of sleep apnea.Central sleep ...
Drugs like Ozempic, Wegovy and Zepbound have transformed how we treat obesity, but more effective treatments could be down ...
Low-income Californians who use Wegovy and similar weight loss drugs will lose their coverage in January. California and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback